Two DC hospitals vie to establish costly cancer treatment option
Two of the region's largest hospital systems are competing to offer a controversial cancer treatment — joining what critics say is a nationwide medical arms race as hospitals scramble for dominance by investing millions of dollars in technology that has not been proven to be better than cheaper alternatives for some cancers. MedStar Georgetown University Hospital and Sibley Memorial Hospital, part of Johns Hopkins Medicine, are vying to establish proton beam therapy, a cutting-edge radiation treatment touted by supporters as more precise in targeting tumors and safer for healthy tissue than conventional X-rays.
- How Top-Ranked MA Plans Earn Their Stars
- How Hospitals Can Become 'Upstreamists'
- CMS Offers Some ACOs $114M for 'Upfront' Costs
- WellPoint Dominates Nearly Half of Markets, AMA Says
- Ebola: Second TX Nurse Diagnosed After Improper Protective Gear Application
- Providers Ask HHS to Address EHR Interoperability Barriers
- 5 Digital Marketing Efforts Every Hospital Should Try
- The Drug Price Reform Debate
- 16 Medicare Advantage Plans Earn 5-Star Ratings
- Ebola: A Call for Designated Hospitals